CAMBRIDGE, Mass., April 07, 2020 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering […]
Expects to report record growth in new paid subscriptions in first quarter, resulting in improving subscription and maintenance revenueRevises first […]
Amounts in $CAD unless otherwise noted Element’s strategy and strong financial position enable Company to withstand business impacts of COVID-19 crisis […]